New Key Statistics Module, Z-Score and F-Score
NAS:XERS Key Ratios
| Market Cap $ M | 381.02 |
| Enterprise Value $ M | 550.49 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 2.03 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 171.00 |
| EPS (TTM) $ | -0.46 |
| Beneish M-Score | -2.57 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 48.70 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -14.56 |
| EV-to-EBITDA | -22.32 |
| PEG | -- |
| Shares Outstanding M | 148.26 |
| Net Margin (%) | -37.58 |
| Operating Margin % | -26.25 |
| Pre-tax Margin (%) | -38.13 |
| Quick Ratio | 1.81 |
| Current Ratio | 2.37 |
| ROA % (ttm) | -19.67 |
| ROE % (ttm) | -1,019.20 |
| ROIC % (ttm) | -20.86 |
| Dividend Yield % | -- |
| Altman Z-Score | -1.51 |
XERS Number of Guru Trades
XERS Volume of Guru Trades
Gurus Latest Trades with NAS:XERS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:XERS is held by these investors
Total 1
Xeris Biopharma Holdings Inc Insider Transactions
No Available Data
News about NAS:XERS
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers